Precision Business Insights has published a report on the global choroidal neovascularization market, estimating its value at USD 7.1 million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 6.22% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/choroidal-neovascularization-market

Market Definition:

The development of new blood vessels in the choroid layer of the eye is known as choroidal neovascularization (CNV). A prevalent cause of neovascular degenerative maculopathy, often known as "wet" macular degeneration, is choroidal neovascularization which is frequently made worse by high myopia, malignant myopic degeneration, or age-related changes.

Drivers:

1)      Growing prevalence in lifestyle change diseases

2)      Rising prevalence of aging population.

The global choroidal neovascularization market segmentation:
1) By Product Type: Intravenous and Intravitreal.
2) By Treatment: Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser Photocoagulation, Low-dose Radiation Therapy, and Surgery.
3) By Diagnosis: Fluorescein Angiography, Indocyanine Green Angiography, Spectral Domain Optical Coherence Tomography, and Others.
4) By Application: Extreme Myopia, Malignant Myopic Degeneration, and Age-Related Developments.
5) By End Users: Hospitals, Specialty Clinics, Homecare, Others.

Regional Overview:
The report also examines the current concerns and their Future Effects on the choroidal neovascularization market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the choroidal neovascularization market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The key players profiled in the global choroidal neovascularization market report are Bausch Health Companies Inc., Bayer AG, Intas Pharmaceuticals, Gilead Sciences, Inc., Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanwa Kagaku Kenkyusho Co. Ltd.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747